EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 174 filers reported holding EAGLE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $335,000 | -66.0% | 7,535 | -68.0% | 0.00% | -70.0% |
| Q1 2021 | $984,000 | -14.1% | 23,570 | -4.2% | 0.01% | -23.1% |
| Q4 2020 | $1,145,000 | +222.5% | 24,595 | +315.9% | 0.01% | +333.3% |
| Q4 2019 | $355,000 | +1.7% | 5,913 | -4.2% | 0.00% | 0.0% |
| Q3 2019 | $349,000 | -21.2% | 6,171 | -22.4% | 0.00% | 0.0% |
| Q2 2019 | $443,000 | +4.7% | 7,950 | -5.0% | 0.00% | 0.0% |
| Q1 2019 | $423,000 | +55.5% | 8,370 | +23.9% | 0.00% | +50.0% |
| Q4 2018 | $272,000 | -44.7% | 6,758 | -4.7% | 0.00% | -33.3% |
| Q3 2018 | $492,000 | -20.6% | 7,094 | -13.5% | 0.00% | -25.0% |
| Q2 2018 | $620,000 | +37.2% | 8,198 | -4.5% | 0.00% | 0.0% |
| Q1 2018 | $452,000 | +15.9% | 8,582 | +17.7% | 0.00% | +33.3% |
| Q4 2017 | $390,000 | -16.1% | 7,294 | -6.4% | 0.00% | 0.0% |
| Q3 2017 | $465,000 | -1.5% | 7,794 | +30.2% | 0.00% | 0.0% |
| Q2 2017 | $472,000 | -4.6% | 5,985 | +0.3% | 0.00% | 0.0% |
| Q1 2017 | $495,000 | -64.5% | 5,969 | -70.1% | 0.00% | -72.7% |
| Q3 2016 | $1,395,000 | +63.7% | 19,933 | -9.3% | 0.01% | +37.5% |
| Q2 2016 | $852,000 | – | 21,965 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 475,755 | $25,068,000 | 24.71% |
| Hudson Executive Capital LP | 971,000 | $51,162,000 | 15.09% |
| Park West Asset Management LLC | 1,051,274 | $55,392,000 | 2.47% |
| U S GLOBAL INVESTORS INC | 19,200 | $1,012,000 | 0.62% |
| Capital Impact Advisors, LLC | 26,317 | $1,387,000 | 0.57% |
| CLARK ESTATES INC/NY | 56,278 | $2,965,000 | 0.47% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 873,131 | $46,005,000 | 0.41% |
| ProQuest Associates IV LLC | 6,777 | $357,000 | 0.41% |
| Granite Investment Partners, LLC | 114,207 | $6,017,000 | 0.40% |
| GLOBEFLEX CAPITAL L P | 30,900 | $1,628,000 | 0.34% |